An observational study in Day-3 Positive of Parasitaemia and Prevalence of Drug Resistance Gene Mutation, sponsored by Myat Htut Nyunt. Completed at 1 site in Myanmar. Open to participants aged 2 Years and older. Per ClinicalTrials.gov, last updated 2014-07-23.
Sponsored by Myat Htut Nyunt · Observational
1,184 studies on the registry are indexed under Malaria; 79 are open to participants now.
This study's enrollment of 91 is below the median of 582 across 204 observational studies indexed under Malaria.
Browse Malaria studies →This is the only study on the registry with Myat Htut Nyunt as lead sponsor.
Counted across the registry records on this site, refreshed daily.
All of the malaria suspected cases were invited to participated in this study from Myanmar-Thailand border and Myanmar-Bangladesh border.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
day-3 parasite positivity
All of the enrolled patients were monitored with appropriate care up to third day and take the samples on day-3.
Time frame: 3 days
Prevalence of the drug resistance marker
By using the dried blood spots, drug resistance markers were detected by molecular method.
Time frame: up to day-3
This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.